Breaking News Instant updates and real-time market news.

PVTL

Pivotal Software

$21.21

0.29 (1.39%)

, SAIC

SAIC

$88.06

-0.22 (-0.25%)

19:00
06/12/18
06/12
19:00
06/12/18
19:00

On The Fly: After Hours Movers

UP AFTER EARNINGS: Pivotal Software (PVTL) up 5.9%... Science Applications International Corporation (SAIC) up 1.3%. ALSO HIGHER: Enphase (ENPH) up 30.0% after buying Sunpower's microinverter business... REGENXBIO (RGNX) up 5.3% after FDA fast track designation for RGX-111... Time Warner (TWX) up 4.4%, CBS (CBS) up 4.2%, 21st Century Fox (FOXA) up 6.9%, Lions Gate (LGF.B), AT&T (T) down 2.8%, Comcast (CMCSA) down 3.3%, Disney (DIS) down 1.9% after court approved Time Warner purchase by AT&T... Scotts Miracle-Gro (SMG) up 3.7% after May activity report and FY18 guidance... Embraer (ERJ) up 2.4% after reports of commercial jet venture with Boeing. DOWN AFTER EARNINGS: H&R Block (HRB) down 19.3%... Oxford Industries (OXM) down 7.8%... Digital Turbine (APPS) down 5.3%. ALSO LOWER: vTv Therapeutics (VTVT) down 25.9% after failed STEADFAST Study data... Oxford Industries (OXM) down 7.8% after Q2 guidance... USA Compression Partners (USAC) down 5.8% after equity offering.

PVTL

Pivotal Software

$21.21

0.29 (1.39%)

SAIC

SAIC

$88.06

-0.22 (-0.25%)

ENPH

Enphase Energy

$4.50

-0.11 (-2.39%)

RGNX

Regenxbio

$56.95

-0.25 (-0.44%)

TWX

Acquired by T

$96.19

-0.05 (-0.05%)

CBS

CBS

$52.39

0.4 (0.77%)

FOXA

Fox Corp.

$40.52

0.38 (0.95%)

LGF.B

Lionsgate

$22.72

-0.05 (-0.22%)

T

AT&T

$34.35

0.16 (0.47%)

CMCSA

Comcast

$32.39

0.38 (1.19%)

DIS

Disney

$104.31

-0.05 (-0.05%)

SMG

Scotts Miracle-Gro

$86.82

-0.02 (-0.02%)

ERJ

Embraer

$26.44

1.54 (6.18%)

HRB

H&R Block

$29.59

0.2 (0.68%)

APPS

Digital Turbine

$1.89

0.18 (10.53%)

VTVT

vTv Therapeutics

$1.89

0.08 (4.42%)

USAC

USA Compression

$18.02

-0.31 (-1.69%)

OXM

Oxford Industries

$92.47

2.39 (2.65%)

  • 12

    Jun

  • 12

    Jun

  • 12

    Jun

  • 12

    Jun

  • 12

    Jun

  • 12

    Jun

  • 19

    Jun

  • 21

    Jun

  • 26

    Jun

  • 13

    Jun

PVTL Pivotal Software
$21.21

0.29 (1.39%)

05/15/18
05/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Weight Watchers (WTW) initiated with a Buy at SunTrust. 2. Spotify (SPOT) initiated with a Sell at Loop Capital. 3. Pivotal Software (PVTL) initiated with an Outperform at William Blair and Credit Suisse, an Overweight at Morgan Stanley and KeyBanc, a Buy at Goldman Sachs, an Equal Weight at Barclays, a Sector Perform at RBC Capital, as well as a Neutral at UBS, Citi, and BofA/Merrill. 4. Level One (LEVL) initiated with an Outperform at Raymond James, Keefe Bruyette, and a Neutral at Piper Jaffray. 5. GrafTech (EAF) initiated with a Buy at Citi and an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/18
FBCO
05/15/18
INITIATION
Target $22
FBCO
Outperform
Pivotal Software initiated with an Outperform at Credit Suisse
Credit Suisse analyst Brad Zelnick started Pivotal Software with an Outperform rating and $22 price target as he believes the company is poised to benefit from the unprecedented digital disruption currently faced by enterprises.
05/15/18
MSCO
05/15/18
INITIATION
Target $24
MSCO
Overweight
Pivotal Software initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Sanjit Singh initiated Pivotal Software with an Overweight rating and $24 price target, offering his view that Pivotal leads the market in transforming software development for businesses and he sees the potential for durable growth of over 35%.
05/15/18
UBSW
05/15/18
INITIATION
Target $20
UBSW
Neutral
Pivotal Software initiated with a Neutral at UBS
UBS analyst Jennifer Swanson Lowe initiated Pivotal Software with a Neutral rating. The analyst said she likes the growth story, but the pace of adoption could be lumpy while the shares already trade in-line with peers. Lowe has a $20 price target on Pivotal Software shares.
SAIC SAIC
$88.06

-0.22 (-0.25%)

05/25/18
05/25/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Enanta (ENTA) initiated with an Outperform at Oppenheimer. 2. VistaGen Therapeutics (VTGN) initiated with an Outperform at Oppenheimer. 3. Engility (EGL) initiated with a Buy at Stifel. 4. ManTech (MANT) initiated with a Hold at Stifel. 5. SAIC (SAIC) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, Reference Link
05/25/18
STFL
05/25/18
INITIATION
Target $85
STFL
Hold
SAIC initiated with a Hold at Stifel
Stifel analyst Joseph DeNardi started SAIC with a Hold rating and $85 price target, saying he views the shares, which trade at a multiple above the group average, as fairly valued given the company's lower than average margins and the risk around its vehicle integration work.
05/17/18
WELS
05/17/18
DOWNGRADE
Target $87
WELS
Market Perform
SAIC downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Edward Caso downgraded SAIC (SAIC) to Market Perform with an $87 price target citing valuation. The analyst coupled the downgrade with an upgrade of ManTech (MANT) to Outperform.
02/12/18
SBSH
02/12/18
NO CHANGE
SBSH
Citi sees services stocks outperforming after CSRA buyout
Citi analyst Jonathan Raviv expects government service stocks to outperform after General Dynamics (GD) announced its acquisition of CSRA (CSRA) for $9.6B. The analyst notes he has Buy ratings on Leidos (LDOS), CACI (CACI), SAIC (SAIC) and a Neutral rating on Booz Allen (BAH). Raviv, however, can't think of another prime interested in consolidating more services. The analyst also expects Buy-rated Harris (HRS) to underperform today as he thinks there was some takeout speculation baked into shares.
ENPH Enphase Energy
$4.50

-0.11 (-2.39%)

04/05/18
ROTH
04/05/18
NO CHANGE
ROTH
Solar 'doges bullet' as inverters/cells/modules sidestep 301 tariffs, says Roth Capital
Roth Capital analyst Philip Shen notes that inverters, solar cells, and solar modules were not on the 301 product list released on the USTR website providing which Chinese imports will be subject to 25% tariffs. A 301 tariff that increases module or inverter costs in the U.S. could have served as another dampener of U.S. solar demand, he contends, adding that the lack of impact represents an overall positive for the industry and positive for most in his coverage universe, including Canadian Solar (CSIQ), Enphase Energy (ENPH), First Solar (FSLR), Hanwah Q CELLS (HQCL), JinkoSolar (JKS), Sunrun (RUN), SolarEdge (SEDG), ReneSola (SOL), Sunworks (SUNW), and Yingli Green Energy (YGE).
04/16/18
ROTH
04/16/18
NO CHANGE
Target $6
ROTH
Buy
Enphase Energy should be bought on any weakness, says Roth Capital
Roth Capital analyst Philip Shen raised his price target for Enphase Energy to $6 from $5.50 after meeting with management. As the company aggressively drives out costs, the analyst expects it to regain share as it rolls out its unique and differentiated IQ7/IQ7x/IQ8 technology. Shen reiterates a Buy rating on the stock.
04/24/18
COWN
04/24/18
NO CHANGE
Target $6
COWN
Outperform
Enphase Energy price target raised to $5.50 from $3.50 at Cowen
Cowen analyst Jeffrey Osborne raised his price target on Enphase Energy to $5.50 from $3.50 citing its successful product transition, market share gains, margin expansion, and an "admirable job" by new management. Osborne reiterated his Outperform rating on Enphase Energy shares.
05/16/18
HCWC
05/16/18
INITIATION
Target $8
HCWC
Buy
Enphase Energy initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Amit Dayal started Enphase Energy with a Buy rating and $8 price target. The company's pace of new product launches, emphasis on cost reductions, and focus on expanding its addressable markets should support near term growth and profitability, Dayal tells investors in a research note.
RGNX Regenxbio
$56.95

-0.25 (-0.44%)

04/09/18
MSCO
04/09/18
DOWNGRADE
MSCO
Equal Weight
AveXis downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz downgraded AveXis (AVXS) to Equal Weight from Overweight following its announcement of an agreement to be acquired by Novartis (NVS) for $218 per share. He added that the buyout premium AveXis garnered should benefit Regenxbio (RGNX) as well.
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Jefferies highlights other gene theraphy players after AveXis takeover
Novartis' (NVS) deal to acquire AveXis (AVXS) for $8.7B should remind investors about the ongoing attractiveness within smid-cap biotech, Jefferies analyst Michael Yee tells investors in a research note. Novartis' two large gene therapy deals in four months will lead to a question of "who's next," the analyst adds. Yee says other mid-late stage gene therapy players include Bluebird Bio (BLUE), Spark Therapeutics (ONCE), BioMarin (BMRN), Abeona Therapeutics (ABEO), Regenxbio (RGNX), Nightstar Therapeutics (NITE) and Voyager Therapeutics (VYGR).
04/18/18
BERN
04/18/18
NO CHANGE
BERN
Spark Therapeutics, uniQure may be potential takeout targets, says Bernstein
Following AveXis (AVXS) acquisition by Novartis (NVS), Bernstein analyst Vincent Chen says the potential next target should have a strong portfolio fit and innovation-oriented scientifically-minded management teams likely comfortable with the technology platform. For acquisition targets, the analyst sees two flavors, namely late stage more de-risked gene therapy companies, for which Spark (ONCE) comes to mind, and less costly but riskier earlier-stage platforms, for which uniQure (QURE), Voyager (VYGR) and REGENXBIO (RGNX) come to mind.
05/09/18
LEHM
05/09/18
NO CHANGE
Target $48
LEHM
Overweight
Regenxbio price target raised to $48 from $38 at Barclays
Barclays analyst Gena Wang raised her price target for Regenxbio to $48 saying the Q1 earnings call highlighted recent progresses of internal and partnered programs. The analyst raised her projection of royalty income from AVXS-101 and increased the technology platform value for the company to account for recent positive developments. She reiterates an Overweight rating on Regenxbio.
TWX Acquired by T
$96.19

-0.05 (-0.05%)

06/07/18
JEFF
06/07/18
DOWNGRADE
Target $35
JEFF
Hold
AT&T downgraded to Hold from Buy at Jefferies
Jefferies analyst John Janedis downgraded AT&T (T) to Hold and lowered his price target for the shares to $35 from $40 after assuming coverage of the name. Pressures in the company's entertainment segment will continue, as virtual multichannel video programming distributors gain share and video options pressure average revenue per user and margins, Janedis tells investors in a research note. He expects the Time Warner (TWX) acquisition to close, but believes there is risk of incremental programming investment at HBO/Turner to drive growth and that the advanced advertising opportunity may take longer to materialize.
05/02/18
BRRR
05/02/18
NO CHANGE
Target $110
BRRR
Outperform
Odds in favor of Time Warner deal closing, says Barrington
Barrington analyst James Goss said he continues to expect the acquisition of Time Warner (TWX) by AT&T (T) to ultimately gain court approval and his Outperform rating in part reflects the significant gap from the AT&T takeout offer. He also sees relatively modest downside risk in the event of the deal being blocked, given the continued fundamental support based on existing Time Warner assets and operations, he tells investors. Goss maintains a $110 price target on Time Warner shares.
06/01/18
RBCM
06/01/18
NO CHANGE
Target $360
RBCM
Outperform
RBC Capital backs Outperform rating on Netflix post U.S., international surveys
RBC Capital analyst Mark Mahaney reiterated an Outperform rating and $360 price target on Netflix (NFLX) shares following "positive" results from surveys in the U.S., France and German that found higher satisfaction trends, a rising willingness to pay for streaming content and high penetration levels. In the U.S., Mahaney noted that the survey found 55% of respondents watch Netflix, a significant lead over YouTube (GOOGL), Amazon (AMZN) and Hulu (DIS, CMCSA, TWX), adding that while Amazon is showing the fastest penetration growth among Streaming services, three years of data show that Prime customers are "more likely to also subscribe to Netflix." He views Netflix as one of the best derivatives off the strong growth in online video viewing and in Internet connect devices.
04/17/18
PIVT
04/17/18
DOWNGRADE
Target $105
PIVT
Hold
Time Warner downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded Time Warner (TWX) to Hold and lowered his price target for the shares to $105 from $108. The stock's value is driven by current trading levels of AT&T (T) under a presumption that the sale of the company goes through, Wieser tells investors in a research note.
CBS CBS
$52.39

0.4 (0.77%)

05/18/18
LOOP
05/18/18
NO CHANGE
Target $60
LOOP
Buy
CBS price target lowered to $60 from $75 at Loop Capital
Loop Capital analyst Alan Gould lowered his price target on CBS (CBS) to $60 but kept his Buy rating after the company board voted to declare a dividend even as the Delaware Court denied the company's request for a temporary restraining order against National Amusements, Inc. The analyst states that despite NAI's comment that it has no intention of forcing a deal, there is now a 60% chance of a CBS-Viacom (VIAB) merger as Les Moonves departs and Bob Bakish takes over running the combined company. In his estimated 30% scenario that there is no merger and Moonves stays as CBS CEO, the analyst assigns CBS a $79 price target. In the remaining 10% possibility of no merger but Moonves is forced out by Shari Redstone, Gould says the stock can trade around $53 per share.
05/17/18
05/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Molson Coors (TAP) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying he sees multiple expansion as unlikely because U.S. beer industry volume trends are getting worse, the company's U.S. share trends are not improving, and demographics favor continued pressure on per capita alcohol consumption. 2. Progressive (PGR) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Meyer Shields citing valuation. 3. CBS (CBS) downgraded to Neutral from Buy at BofA/Merrill with analyst Jessica Reif saying the lawsuit brought by CBS and the special committee alleging a breach of fiduciary duty by the National Amusements Inc. is a significant overhang for shares and will constrain outperformance until a ruling. 4. Canadian National (CNI) downgraded to Neutral on valuation at Macquarie with analyst Konark Gupta citing valuation. 5. Jounce Therapeutics (JNCE) downgraded to Market Perform from Outperform at Wells Fargo with analyst Jim Birchenough saying overall response rates for JTX-2011 monotherapy in gastric cancer and in triple negative breast cancer, as well as for JTX-2011 plus Opdivo in gastric cancer and in triple negative breast cancer are "underwhelming" and "not competitive with other investigational drugs." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
05/17/18
DOWNGRADE
Target $58

Neutral
CBS downgraded to Neutral on lawsuit overhang at BofA/Merrill
As previously reported, BofA/Merrill downgraded CBS to Neutral from Buy and cut its price target to $58 from $78. Analyst Jessica Reif said the lawsuit brought by CBS and the special committee alleging a breach of fiduciary duty by the National Amusements Inc. is a significant overhang for shares and will constrain outperformance until a ruling. Further, Reif sees increased risk that CEO Leslie Moonves could leave the company, which would elevate execution risk.
05/17/18
WELS
05/17/18
NO CHANGE
WELS
Market Perform
CBS shares likely return to mid-$60's with no merger, says Wells Fargo
Wells Fargo analyst Marci Ryvicker sees three potential paths unfolding for CBS (CBS) and Viacom (VIAB). The first being CBS remaining a standalone company with Les Moonves in charge. In this scenario the analyst sees CBS shares re-rating to $64, but ultimately being worth $78, and Viacom retreating to $26.50, but being worth $35-$39. The second scenario has CBS and Viacom merging with Moonves in charge. Under this, the new CBS is worth $55 per share with Viacom taken out at $32, Ryvicker tells investors in a research note. Her third scenario has CBS and Viacom merging with Bob Bakish in charge. The analyst values the new CBS at $44 per share in this scenario. At this point, Ryvicker favors a go-it-alone strategy for CBS. She also likes what Bakish is doing at Viacom. The analyst keeps Market Perform rating on both stocks, however, citing the lack of visibility on the outcome or timing.
FOXA Fox Corp.
$40.52

0.38 (0.95%)

05/01/18
MSCO
05/01/18
NO CHANGE
Target $130
MSCO
Overweight
Disney trades at 'historic discount' while building out OTT, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne believes Disney's (DIS) new segment presentation could benefit shares by highlighting Disney's Over-the-top, or OTT, opportunity and providing visibility into the earnings power of its core businesses. If Fox (FOXA) is included and Hulu is consolidated, Swinburne estimates Disney's OTT and Direct-to-consumer businesses grow to roughly $6.5B in gross annual revenues by FY20, while noting that the stock is currently trading at a historical discount to the S&P 500. He maintains an Overweight rating and $130 price target on Disney shares.
03/15/18
LOOP
03/15/18
INITIATION
Target $130
LOOP
Buy
Disney initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Disney (DIS) with a Buy rating and $130 price target. The analyst views the Disney/21st Century Fox (FOXA) deal as a "win/win," positioning Disney to be a more competitive player in the global streaming business.
05/22/18
NEED
05/22/18
NO CHANGE
Target $70
NEED
Buy
WWE price target raised to $70 from $45 at Needham
Needham analyst Laura Martin raised her price target on WWE to $70 following press reports that the company will renew its USA Network / NBC deals for 3-times its current value and also license its SmackDown programming to Fox (FOXA) for 3-times its current value. The analyst adds that the new contract payments are expected to begin in Q4 of 2019. Martin also notes that the terms suggest that WWE's direct-to-consumer offering did not cannibalize the US TV license growth, keeping her Buy rating on the shares.
05/10/18
OPCO
05/10/18
NO CHANGE
Target $42
OPCO
Outperform
Comcast acquisition of Fox would make strategic, financial sense, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that press reports stated Comcast (CMCSA) has lined up $60B in financing to make an all-cash offer for Fox's (FOXA) entertainment assets, representing a 15% premium to Disney's (DIS) offer. While he thinks this has caused half the 30% decline in Comcast's stock year to date, the analyst believes it does make strategic and financial sense, and Comcast has a great track record on acquisitions. Horan thinks a joint NBC/Fox is a content powerhouse while expanding the company's presence in Europe through Sky (SKYAY), and slashing OTT video risk. The analyst reiterates an Outperform rating and $42 price target on Comcast's shares.
LGF.B Lionsgate
$22.72

-0.05 (-0.22%)

05/17/18
KEYB
05/17/18
NO CHANGE
KEYB
Sector Weight
Lionsgate risk/reward 'slightly positive' after selloff, says KeyBanc
KeyBanc analyst Evan Wingren sees a "slightly positive" risk/reward on Lionsgate following the recent pullback, which the analyst attributes to lower growth rates and likely continued pressure on Starz subs and profits. The analyst, however, keeps a Sector Weight rating on the name. He says confidence in the company's growth reacceleration or M&A potential would likely get him more constructive.
03/15/18
LOOP
03/15/18
INITIATION
Target $36
LOOP
Buy
Lionsgate initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Lionsgate (LGF.B) with a Buy rating and $36 price target. The company operates in the "sweet spot" of the media industry, content creation, and is not as impacted by advertising or cord cutting, the analyst contends. The analyst views the recent pullback in the shares as a buying opportunity.
05/23/18
LOOP
05/23/18
NO CHANGE
Target $36
LOOP
Buy
Lionsgate stock offers 'attractive entry price', says Loop Capital
Loop Capital analyst Alan Gould maintains his Buy rating and $36 price target on Lionsgate ahead of its Q4 results tomorrow, saying the company remains well positioned in the "sweet spot of the media industry" and content creation. The analyst further notes that Lionsgate would also be an attractive asset amid a consolidating industry environment, and believes that the lowered expectations from last quarter create an attractive entry point for investors.
03/21/18
LOOP
03/21/18
NO CHANGE
Target $36
LOOP
Buy
Lionsgate shares offer attractive entry at current levels, says Loop Capital
After hosting a dinner with CFO James Barge, Loop Capital analyst Alan Gould continues to believe Lionsgate Entertainment is well positioned "operating in the sweet spot" of the media industry and content creation. The company offers an "attractive asset" in a consolidating industry environment, Gould tells investors in a research note. The analyst thinks lower expectations have created an attractive entry price. He keeps a Buy rating on Lionsgate with a $36 price target.
T AT&T
$34.35

0.16 (0.47%)

05/03/18
RHCO
05/03/18
NO CHANGE
Target $35
RHCO
Hold
AT&T price target lowered to $35 from $40 at SunTrust
SunTrust analyst Greg Miller lowered his price target on AT&T to $35 and kept his Hold rating, saying the company's Q1 results "highlight the various challenges" that it faces. While churn is improving and pre-paid net subscriber additions growth continues, the analyst sees a shift from Pay-TV to OTT model weighing on revenue and margins in the Entertainment and Internet segments.
05/01/18
DBAB
05/01/18
NO CHANGE
Target $36
DBAB
Hold
AT&T multiples at 'historical lows,' says Deutsche Bank
Deutsche Bank analyst Matthew Niknam sees value in shares of AT&T with "multiples at historical lows." Despite lowering his earnings estimates by 1%-2%, the analyst says the stock's "heavily discounted valuation is noteworthy." AT&T currently trades at 9.6 times 2018 earnings estimates, which marks its historical trough, Niknam tells investors in a research note. He believes the 6.1% dividend yield should provide additional downside support. Nonetheless, Niknam lowered his price target for AT&T to $36 from $41 and keeps a Hold rating on the shares.
CMCSA Comcast
$32.39

0.38 (1.19%)

06/07/18
JEFF
06/07/18
INITIATION
Target $41
JEFF
Buy
Comcast assumed with a Buy at Jefferies
Jefferies analyst John Janedis assumed coverage of Comcast with a Buy rating while lowering his firm's price target to $41 from $50. The analyst sees an attractive entry point at current share levels given the "appealing balance of growth and shareholder returns." The shares have overreacted to the potential acquisition of both Sky and Fox, Janedis tells investors in a research note. He believes investors are too focused on the short-term shift from buyback to acquisition mode, rather than the long-term potential for a combined entity.
05/17/18
KEYB
05/17/18
UPGRADE
Target $38
KEYB
Overweight
KeyBanc upgrades Comcast to Overweight on coverage transfer
KeyBanc upgraded Comcast to Overweight from Sector Weight after transferring coverage to Brandon Nispel. The analyst has a $38 price target for the shares. Uncertainty about Comcast's acquisition aspirations in media has created a buying opportunity, Nispel told investors last night in a research note. Either the company's cable business is undervalued, or investors get NBCU for essentially free, the analyst contends. He believes Comcast is trading at attractive valuation relative to peers.
05/16/18
KEYB
05/16/18
INITIATION
Target $38
KEYB
Overweight
Comcast coverage transferred with an Overweight at KeyBanc
KeyBanc analyst Brandon Nispel started coverage on Comcast with an Overweight and $38 price target telling investors uncertainty about its media M&A aspirations has created a buying opportunity. Nispel said Comcast's cable business is undervalued, or investors get NBCU for almost free, creating an attractive valuation.
DIS Disney
$104.31

-0.05 (-0.05%)

05/09/18
MSCO
05/09/18
NO CHANGE
Target $130
MSCO
Overweight
Morgan Stanley says Disney's Q2 showcases strong profit potential of 'IP' units
Morgan Stanley analyst Benjamin Swinburne said Disney's Q2 results showcase the strong profit growth potential of the company's intellectual property, or "IP," driven segments, namely the Film and Parks units. The better than expected results also highlight improvement at core Media Networks despite some modest dilution from OTT investments, added Swinburne, who keeps an Overweight rating and $130 price target on Disney shares.
SMG Scotts Miracle-Gro
$86.82

-0.02 (-0.02%)

06/01/18
JPMS
06/01/18
DOWNGRADE
Target $85
JPMS
Underweight
Scotts Miracle-Gro downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Scotts Miracle-Gro to Underweight and lowered his price target for the shares to $85 from $95.
06/01/18
JPMS
06/01/18
DOWNGRADE
Target $85
JPMS
Underweight
Scotts Miracle-Gro downgraded to Underweight with $85 target at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Scotts Miracle-Gro to Underweight from Neutral and lowered his price target for the shares to $85 from $95. The company faces challenges both in its core consumer business and in its hydroponics operation, which serves the cannabis market, Zekauskas tells investors in a research note. He sees a low probability of the stock trading higher on Scotts' mid-June update at an investor conference. He also believes the probability of "stellar" fiscal Q3 results is low.
06/01/18
06/01/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Southwest (LUV) downgraded to In-Line from Outperform at Imperial Capital with analyst Michael Derchin saying he expects Southwest to face unit revenue pressures through fiscal 2019 from higher capacity growth in the "weaker" off-peak period as well as heightened competition in California and Denver. 2. AbbVie (ABBV) downgraded to Neutral from Overweight at Piper Jaffray with analyst Christopher Raymond saying the stock's risk/reward, while once compelling on the reward side, may be skewing increasingly toward risk. 3. Scotts Miracle-Gro (SMG) downgraded to Underweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the company faces challenges both in its core consumer business and in its hydroponics operation, which serves the cannabis market. 4. Owens Corning (OC) downgraded to Hold from Buy at Argus. 5. Perry Ellis (PERY) downgraded to Market Perform from Outperform at IFS Securities and to Neutral from Buy at Sidoti. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/18
05/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Gap (GPS) upgraded to Outperform from Market Perform at Telsey Advisory. 2. CBS (CBS) upgraded to Outperform from Market Perform at Bernstein with the firm saying it views the probability of a CBS-Viacom (VIAB) re-merger as close to zero, for many years to come. 3. Ulta Beauty (ULTA) upgraded to Outperform from Perform at Oppenheimer with analyst Rupesh Parikh saying he still sees the potential for more gains and outperformance from current levels. 4. Valeant (VRX) upgraded to Buy from Neutral at Mizuho with analyst Irina Koffler saying adjusting individual product growth estimates has made her more constructive on Valeant's turnaround story. 5. Scotts Miracle-Gro (SMG) upgraded to Buy from Hold at SunTrust with analyst William Chappell saying he believes the bottom in the stock price has been reached, leading to its usual "counter seasonal trend of outperformance" given that the stock has outperformed the S&P500 from June to January in the past 11 of 15 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ERJ Embraer
$26.44

1.54 (6.18%)

12/22/17
JEFF
12/22/17
NO CHANGE
Target $312
JEFF
Buy
Jefferies sees possible Embraer deal modestly accretive to Boeing
Jefferies analyst Sheila Kahyaoglu estimates an acquisition of Embraer (ERJ), done at a 40% premium, would be 2%, or 20c, accretive to Boeing's (BA) core earnings per share in 2020. While the transaction would be strategically beneficial for Boeing's commercial aircraft and services portfolio, it is not clear what restrictions the Brazilian government would place on any combination, Kahyaoglu tells investors in a research note. She has a Buy rating on Boeing with a $312 price target.
04/25/18
SBSH
04/25/18
DOWNGRADE
Target $29
SBSH
Neutral
Embraer downgraded to Neutral from Buy at Citi
Citi downgraded Embraer to Neutral with a $29 price target.
05/22/18
DRXL
05/22/18
DOWNGRADE
DRXL
Hold
Embraer downgraded to Hold from Buy at Drexel Hamilton
05/22/18
05/22/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BofI Holding (BOFI) downgraded to Neutral from Buy at Compass Point with the firm citing valuation. 2. Sasol (SSL) downgraded to Hold from Buy at Deutsche Bank with analyst Pavel Kushnir citing valuation. 3. Cameco (CCJ) downgraded to Sector Perform from Outperform at RBC Capital. 4. Embraer (ERJ) downgraded to Hold from Buy at Drexel Hamilton. 5. Manchester United (MANU) downgraded to Hold from Buy at Deutsche Bank with analyst Clay Griffin citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HRB H&R Block
$29.59

0.2 (0.68%)

03/05/18
NRCS
03/05/18
UPGRADE
NRCS
Buy
H&R Block upgraded to Buy from Neutral at Northcoast
03/07/18
BRRR
03/07/18
NO CHANGE
BRRR
H&R Block Q3 results beat on top, bottom lines, says Barrington
Barrington analyst Alexander Paris Jr. said H&R Block beat its Q3 expectations and noted that through the first half of this year's tax season, H&R Block's client volumes have improved. Paris also noted that while the IRS reported a decline in e-files of 0.4% through February 23, H&R Block reported an increase of 3.4%. Paris reiterated an Outperform rating and $32 price target on H&R Block shares.
03/12/18
FBCO
03/12/18
NO CHANGE
Target $195
FBCO
Outperform
H&R Block's DIY e-filings growth bodes well for Intuit, Credit Suisse says
Credit Suisse analyst Michael Nemeroff raised his price target on Intuit (INTU) to $195 from $185 and maintained an Outperform rating. In a research note to investors, the analyst said recent results at H&R Block (HRB) indicating "strong" growth in do-it-yourself e-filings bode well for "DIY leader" Intuit. H&R Block said DIY e-filings were up 6.2% year over year through February 23rd vs. IRS growth of 2.4% int he same period, suggesting that H&R Block is performing well this year in DIY, which he views as a positive read-across for Intuit. He also noted that while H&R Block's 6.2% DIY growth appears impressive, "it's growing off a much smaller base" than Intuit.
03/27/18
GSCO
03/27/18
INITIATION
Target $28
GSCO
Neutral
H&R Block initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst George Tong started H&R Block with a Neutral rating and $28 price target. The analyst rolled out coverage on the Americas Business Services sector with an Attractive rating.
APPS Digital Turbine
$1.89

0.18 (10.53%)

03/27/18
RILY
03/27/18
NO CHANGE
Target $2.8
RILY
Buy
Digital Turbine should be bought on Facebook-related pullback, says B. Riley FBR
B. Riley FBR analyst Sameet Sinha recommends buying shares of Digital Turbine (APPS) following the recent 16% pullback in the shares. The analyst believes the selloff is likely caused by Facebook's (FB) alleged data misuse. Digital Turbine creates data vaults between carriers and partners, and "hence is actually aiding privacy initiatives," Sinha tells investors in a research note. The analyst keeps a Buy rating on the shares with a $2.80 price target.
04/26/18
RILY
04/26/18
NO CHANGE
Target $2.8
RILY
Buy
Digital Turbine pullback brings buying opportunity, says B. Riley FBR
B. Riley FBR analyst Sameet Sinha views the recent pullback in shares of Digital Turbine as a buying opportunity. The analyst sees several catalysts ahead and reiterates a Buy rating on the shares with a $2.80 price target.
VTVT vTv Therapeutics
$1.89

0.08 (4.42%)

04/10/18
GHSC
04/10/18
DOWNGRADE
GHSC
Neutral
vTv Therapeutics downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Corey Davis downgraded vTv Therapeutics to Neutral and slashed its price target to $1 from $14 following the announcement that results from the company's Phase 3 study of azeliragon in people with mild Alzheimer's disease did not meet either co-primary efficacy endpoint.
04/10/18
NORL
04/10/18
DOWNGRADE
NORL
Market Perform
vTv Therapeutics downgraded to Market Perform from Outperform at Northland
04/10/18
ROTH
04/10/18
DOWNGRADE
Target $1
ROTH
Neutral
vTv Therapeutics downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Robert LeBoye downgraded vTv Therapeutics to Neutral from Buy as Phase III fails to meet co-primary endpoints. The analyst also lowered his price target on the shares to $1 from $17.
04/10/18
04/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Monsanto (MON) downgraded to Market Perform from Outperform at BMO Capital with analyst Joel Jackson citing the rising likelihood of the acquisition by Bayer (BAYRY) after yesterday's reports of approval of the merger by the U.S. Department of Justice. 2. Hershey (HSY) downgraded to Sell from Neutral at UBS with analyst Steven Strycula saying Hershey's portfolio is over-exposed to slowing category consumption, intensifying competition, and rising cocoa prices. 3. Cullen/Frost (CFR) downgraded to Underperform from Market Perform at Raymond James. 4. vTv Therapeutics (VTVT) downgraded to Hold from Buy at Stifel, to Neutral from Buy at Seaport Global, Piper Jaffray, and Roth Capital, as well as to Market Perform from Outperform at Northland. 5. Radian Group (RDN) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Dwelle citing the latest reduction in borrower-paid premium rates at MGIC Investment (MTG) and saying he believes sentiment in the space will be negatively impacted. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
USAC USA Compression
$18.02

-0.31 (-1.69%)

03/22/18
JPMS
03/22/18
UPGRADE
Target $13
JPMS
Overweight
Archrock upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Andrew Burd upgraded Archrock (AROC) to Overweight and raised his price target for the shares to $13 from $12. The analyst thinks the recent FERC-induced master limited partnership sector selloff creates an attractive entry point for contract compression securities. The analyst cites valuation for his upgrade of Archrock following the recent pullback in the shares. USA Compression (USAC) remains his top pick in Contract Compression.
01/17/18
RILY
01/17/18
UPGRADE
Target $21
RILY
Buy
USA Compression upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Robert Balsamo upgraded USA Compression to Buy and raised his price target for the shares to $21 from $18. The analyst believes the acquisition of Energy Transfer Partners' compression business reduces the likelihood of a distribution cut.
01/19/18
JPMS
01/19/18
UPGRADE
Target $22
JPMS
Overweight
USA Compression upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Andrew Burd upgraded USA Compression Partners to Overweight and raised his price target for the shares to $22 from $19. Following the acquisition of CDM Resource Management, USA Compression has the "greatest re-rating opportunity among peers," Burd tells investors in a research note. The analyst believes the company is on its best financial footing since the 2013 initial public offering.
03/05/18
JANY
03/05/18
UPGRADE
Target $21
JANY
Buy
USA Compression upgraded to Buy from Neutral at Janney Capital
Janney Capital analyst Michael Gyure upgraded USA Compression to Buy from Neutral as he believes the acquisition of Energy Transfer Partners' (ETP) CDM subsidiaries, expected to close later in the first half of this year, will be transformative and give USA a more balanced geographic footprint. He increased his fair value estimate on USA Compression shares to $21 from $19.
OXM Oxford Industries
$92.47

2.39 (2.65%)

06/07/18
DADA
06/07/18
NO CHANGE
Target $107
DADA
Buy
Oxford Industries price target raised to $107 from $91 at DA Davidson
DA Davidson analyst Michael Kawamoto raised his price target for Oxford Industries to $107 ahead of the company's Q1 results on June 12. The analyst expects a solid Q1 report with positive commentary for the year. Lilly's increasing brand momentum and easier comps to 2017, and Tommy's improving operations should make 2018 "another productive year," Kawamoto tells investors in a pre-earnings research note. He believes the Q1 guidance is achievable and reiterates a Buy rating on Oxford Industries.
04/02/18
RHCO
04/02/18
NO CHANGE
Target $90
RHCO
Buy
Oxford Industries price target lowered to $90 at SunTrust on reduced sales view
SunTrust analyst Pamela Quintiliano lowered her price target on Oxford Industries to $90 from $92 following the company's Q4 earnings and below-consensus outlook for Q1. Quintiliano says that the company's reduced dependence on wholesale channels and higher marketing costs are having a "disproportionate" early 2018 impact, but adds that she remains impressed with its "unique positioning, focus on brand preservation and future growth prospects with existing brands". The analyst keeps her Buy rating on Oxford Industries.
01/09/18
RHCO
01/09/18
NO CHANGE
Target $90
RHCO
Buy
Oxford Industries price target raised to $90 from $70 at SunTrust
SunTrust analyst Pamela Quintiliano raised her price target on Oxford Industries to $90 after the company backed its FY17 guidance and announced "solidly positive" comps and gross margin expansion in a filing ahead of the ICR conference. Quintiliano adds that she is "encouraged" by her meeting with the company management and believes the recent momentum in the stock is sustainable. The analyst keeps her Buy rating on Oxford Industries.
04/02/18
DADA
04/02/18
NO CHANGE
Target $91
DADA
Buy
Oxford Industries' marketing investment is the right step, says DA Davidson
DA Davidson analyst Andrew Burns kept his Buy rating and $91 price target on Oxford Industries, saying that while the company's incremental $12M investment reduces his FY18 EPS forecast to $4.55 from $4.78, it is the right step in the long term toward sustaining its growth momentum in the current retail environment. Burns adds that Oxford Industries' Q4 results were encouraging, with growth acceleration in the Lilly segment as well as gross margin improvement of 1.7% setting up the company for "another solid year".

TODAY'S FREE FLY STORIES

11:25
05/23/19
05/23
11:25
05/23/19
11:25
General news
Treasury announced $113 B in shorter coupons for auction »

Treasury announced $113 B…

11:25
05/23/19
05/23
11:25
05/23/19
11:25
Conference/Events
Stephens medical devices analyst to hold a group luncheon »

Medical Devices &…

ECA

Encana

$6.05

-0.435 (-6.71%)

11:20
05/23/19
05/23
11:20
05/23/19
11:20
Options
Notable call buy in Encana as shares dip »

Notable call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTOO

T2 Biosystems

$1.88

-0.685 (-26.76%)

11:19
05/23/19
05/23
11:19
05/23/19
11:19
Hot Stocks
T2 Biosystems highlights clinical data at ECCMID, MAD-ID meetings »

T2 Biosystems highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/23/19
05/23
11:17
05/23/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/23/19
05/23
11:16
05/23/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/23/19
05/23
11:15
05/23/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
05/23/19
05/23
11:15
05/23/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

MICT

Micronet Enertec

$0.99

(0.00%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
Micronet Enertec receives two orders totaling $1.3M for SmartHub platform »

MICT announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$19.64

-0.31 (-1.55%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
EQT Corporation files definitive proxy, mails letter to shareholders »

EQT Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$32.60

-1.81 (-5.26%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Downgrade
Huazhu Group rating change  »

Huazhu Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

USO

United States Oil Fund

$12.09

-0.66 (-5.18%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Options
Customer rolls US Oil ETF puts for 233% gain as oil sells off »

Customer rolls US Oil ETF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

11:09
05/23/19
05/23
11:09
05/23/19
11:09
Syndicate
Rattler Midstream opens at $18.06, IPO priced at $17.50 per share »

Rattler Midstream (RTLR)…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

FCX

Freeport McMoRan

$9.94

-0.11 (-1.09%)

11:05
05/23/19
05/23
11:05
05/23/19
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

IBM

IBM

$132.49

-3.53 (-2.60%)

11:04
05/23/19
05/23
11:04
05/23/19
11:04
Hot Stocks
ProcessMap, IBM announce joint initiative to develop IoT solutions »

ProcessMAP and IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

11:04
05/23/19
05/23
11:04
05/23/19
11:04
General news
Kansas City Fed Manufacturing Index Level data reported »

May Kansas City Fed…

LB

L Brands

$24.88

0.59 (2.43%)

10:59
05/23/19
05/23
10:59
05/23/19
10:59
On The Fly
Analysts remain cautious on L Brands despite stronger quarter »

Shares of L Brands (LB)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 22

    Aug

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:57
05/23/19
05/23
10:57
05/23/19
10:57
Syndicate
Breaking Syndicate news story on IDEAYA Biosciences »

IDEAYA Biosciences opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CNX

CNX Resources

$7.56

-0.26 (-3.32%)

10:50
05/23/19
05/23
10:50
05/23/19
10:50
Options
Size put option block in CNX after calls bought yesterday »

Size put option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

10:50
05/23/19
05/23
10:50
05/23/19
10:50
General news
Treasury Action: yields have extended lower as Wall Street sinks »

Treasury Action: yields…

AZZ

AZZ Inc.

$43.62

(0.00%)

10:46
05/23/19
05/23
10:46
05/23/19
10:46
Hot Stocks
AZZ Inc. discloses change in independent registered public accounting firm »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$39.97

-0.22 (-0.55%)

10:45
05/23/19
05/23
10:45
05/23/19
10:45
Hot Stocks
GSK to change sales representative incentive program »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
he April U.S. new home sales report beat estimates »

The April U.S. new home…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Kansas City Fed Manufacturing Index Level to be reported at 11:00 »

May Kansas City Fed…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.